Non Hodgkins Lymphoma
Mostrando 1-9 de 9 artigos, teses e dissertações.
-
1. Avaliação do impacto dos fatores geográficos e socioeconômicos na apresentação inicial da criança e do adolescente com câncer / Impact of geographic and socioeconomic factors in the staging from pediatric oncology patients
The early diagnosis of cancer is a fundamental goal in pediatric oncology because it allows an opportunity for timely treatment while the disease is still in its earliest stages. The aim of this study was to evaluate the association between sociodemographic variables and stage disease. Retrospective analysis was performed in malignant tumors patients admitte
Publicado em: 2010
-
2. Gastric extranodal non-Hodgkins lymphoma: retrospective study at the Hematology Department of the Clinic Hospital of the University of São Paulo / Linfoma não Hodgkin extralinfonodal gástrico: estudo retrospectivo do Serviço de Hematologia do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Aproximadamente 40% dos casos de Linfoma não Hodgkin (LNH) se originam fora dos linfonodos, sendo então denominados linfomas extralinfonodais. No trato gastrointestinal (TGI), o estômago é o local mais freqüentemente envolvido, representado pelo linfoma MALT e pelo linfoma difuso de grandes células B (LDGCB). No Brasil, apesar da sua freqüência e imp
Publicado em: 2007
-
3. Indução de quimerismo hematopoetico misto com fludarabina e irradiação corporal total pre transplante de celulas progenitoras perifericas, em pacientes com neoplasias hematologicas / NST is feasible and safe for high risk hematopoietic
Background and Objectives. High mortality rate after allogeneic hematopoietic stem cell transplantation (HSCT) with myeloablative conditioning prompted us to offer HSCT with non-myeloablative conditioning (NST). Design and Methods. Between July, 2001 and October, 2005, 26 patients [acute myeloid leukemia, n=1; chronic myeloid leukemia, n=1; Hodgkin?s lymphom
Publicado em: 2006
-
4. Linfoma não-Hodgkin difuso de grandes células B: Características clínicas, tratamento e prognóstico com os esquemas quimioterápicos CHOP e CHOP-Bleo / Diffuse Non-Hodgkins Lymphoma of Great B Cells: Clinical Characteristics, Treatment and Prognostic with CHOP Chemotherapies Schemes and CHOP-BLEO
O linfoma difuso de grandes células B (LDGCB) corresponde a 50 % dos casos de linfoma não-Hodgkin (LNH). Seu tratamento de escolha é a quimioterapia de associação, em especial o esquema CHOP (ciclofosfamida, doxorrubicina, vincristina e prednisona), considerado o tratamento inicial padrão dos LDGCB. Variações deste esquema, como o protocolo CHOP-Bleo
Publicado em: 2006
-
5. Cancer in young people in the north of England, 1968-85: analysis by census wards.
OBJECTIVE--To determine whether the seeming excess of childhood leukaemia and lymphoma identified in Seascale, Cumbria, UK, remains unusual when put into a wider context. DESIGN--Analysis of cancer incidence by geographical area. SETTING--The north of England including the Northern and North Western Regional Health Authority regions and the Southport and Sou
-
6. Lactic acidosis, non-Hodgkins lymphoma and the acquired immunodeficiency syndrome.
-
7. Structure and expression of the oncogene c-myc in fresh tumor material from patients with hematopoietic malignancies.
c-myc is the cellular gene homologous to the transforming sequence of MC29, an acute avian retrovirus. The human c-myc gene was cloned and used to study the structure and expression of c-myc in a variety of human hematopoietic malignancies. In a careful study of 106 patients, c-myc RNA was found to be expressed at elevated levels in tumor cells of 17 leukemi
-
8. Increased aminoglycoside dosage requirements in hematologic malignancy.
Aminoglycoside pharmacokinetic parameters were studied prospectively in 27 patients with an underlying hematologic malignancy and fever associated with neutropenia and in 18 control patients. Pharmacokinetic parameters and dosages were determined by linear regression analysis of a one-compartment model by the method of Sawchuk et al. (R. J. Sawchuk, D. E. Za
-
9. The Catenin p120ctn Interacts with Kaiso, a Novel BTB/POZ Domain Zinc Finger Transcription Factor
p120ctn is an Armadillo repeat domain protein with structural similarity to the cell adhesion cofactors β-catenin and plakoglobin. All three proteins interact directly with the cytoplasmic domain of the transmembrane cell adhesion molecule E-cadherin; β-catenin and plakoglobin bind a carboxy-terminal region in a mutually exclusive manner, while p120 binds
American Society for Microbiology.